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Abstract 
AIMS: To display a liver-specific ligand on the hepatitis B virus core particles for cell-
targeting delivery. METHODS AND RESULTS: A liver cell-binding ligand (preS1) was 
fused at the N-terminal end of the hepatitis B core antigen (HBcAg), but the fusion protein 
(preS1His(6) HBcAg) was insoluble in Escherichia coli and did not form virus-like particles 
(VLPs). A method to display the preS1 on the HBcAg particle was established by 
incorporating an appropriate molar ratio of the truncated HBcAg (tHBcAg) to the 
preS1His(6) HBcAg. Gold immunomicroscopy showed that the subunit mixture reassembled 
into icosahedral particles, displaying the preS1 ligand on the surface of VLPs. Fluorescence 
microscopy revealed that the preS1 ligand delivered the fluorescein-labelled VLPs into the 
HepG2 cells efficiently. CONCLUSIONS: Chimeric VLPs containing the insoluble 
preS1His(6) HBcAg and highly soluble tHBcAg were produced by a novel incorporation 
method. The preS1 ligand was exposed on the surface of the VLPs and was shown to deliver 
fluorescein molecules into liver cells. SIGNIFICANCE AND IMPACT OF STUDY: The 
newly established incorporation method can be used in the development of chimeric VLPs 
that could serve as potential nanovehicles to target various cells specifically by substituting 
the preS1 ligand with different cell-specific ligands. 
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